Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
78 Cards in this Set
- Front
- Back
Key Features & Essentials of Diagnosis
(Hypertrophic Cardiomyopathy) |
• Dyspnea
• Systolic ejection murmur (w/ characteristic changes during bedside maneuvers) • Markedly asymmetric LVH on ECHO • Normal or hyperkinetic LV systolic fxn |
|
General Considerations: Autosomal Genetic Disorder (Hypertrophic Cardiomyopathy)
|
HC is an autosomal genetic disorder. Cuaed by abnormalities in genes that encode myocardial sarcomeric proteins.
|
|
General Considerations: Varying Expression (Hypertrophic Cardiomyopathy)
|
Asymptomatic -> disabling
|
|
General Considerations: Asymmetric LVH in 2/3rd (Hypertrophic Cardiomyopathy)
|
Septum or, rarely, apex involved; the rest concentric LVH.
|
|
General Considerations: Histology (Hypertrophic Cardiomyopathy)
|
Myofiber disarray with undersized intramural arteries for the mass of myocardium.
|
|
General Considerations: Hyperdynamic Function (Hypertrophic Cardiomyopathy)
|
The left ventricle cavity is usually small and shows hyperdynamic function.
|
|
General Considerations: Symmetric Hypertrophy (Hypertrophic Cardiomyopathy)
|
Intracavitary gradients that worsen with increased contractile stimuli and improve with increased afterload.
|
|
General Considerations: Asymmetric septal hypertrophy (Hypertrophic Cardiomyopathy)
|
Characteristic systolic murmur that varies in intensity with loading conditions.
|
|
General Considerations: Mitral Regurgitation (Hypertrophic Cardiomyopathy)
|
Systolic anterior movement of the mitral valve often leads to mitral regurgitation.
|
|
Symptoms and Signs (Hypertrophic Cardiomyopathy)
|
• Could show no symptoms (asymptomatic)
• Dyspnea, fatigue • Chest pain • Syncope • Palpitation |
|
Fact: The No. 1 cause for athlete death under 35... (Hypertrophic Cardiomyopathy)
|
...is Genetic Autosomal Dominant
|
|
Physical Exam Findings (Hypertrophic Cardiomyopathy)
|
• May be unremarkable
• Left ventricle lift • S4 • Systolic ejections murmur (increases in intensity with maneuvers that decrease left ventricular filling, such as standing; and softens with increased filling, such as squatting. |
|
Differential Diagnosis (Hypertrophic Cardiomyopathy)
|
• Left ventricular hypertrophy secondary to other conditions (e.g. hypertension)
• Aortic stenosis with marked left ventricular hypertrophy • Restrictive cardiomyopathy with hypertrophy (such as amyloidosis) • Ischemic heart disease with compensatory septal hypertrophy • Athlete's heart |
|
Lab Tests (Hypertrophic Cardiomyopathy)
|
• Increased BNP
• Appropriate genetic abnormality |
|
Electrocardiography (Hypertrophic Cardiomyopathy)
|
• Nonspecific abnormalities
• LVH • Apical variant will have giant negative T waves in precordial leads |
|
Imaging Studies: ECHO (Hypertrophic Cardiomyopathy)
|
ECHO: hypertrophy, MV problems, intracavitary gradients
|
|
Imaging Studies: Nuc (Hypertrophic Cardiomyopathy)
|
Nuc: may show infarct and ischemia in the absence of any actual CAD
|
|
Diagnostic Procedures (Hypertrophic Cardiomyopathy)
|
Cardiac catheterization: better at measuring intracavitary gradients and can also exclude CAD while you're at it.
|
|
Medications (Hypertrophic Cardiomyopathy)
|
Prevent Heart Failure: Beta blockers, calcium channel blockers and antiarrhythmic agents as appropriate
|
|
Therapeutic Procedures (Hypertrophic Cardiomyopathy)
|
• Septal involvement: Intracoronary ethanol septal ablation
• Pacemaker to set atrioventricular delay to minimize left ventricular outflow tract gradient • AICD b/c patients at risk for ventricular arrhythmias |
|
Surgery (Hypertrophic Cardiomyopathy)
|
• Septal myectomy to relieve left ventricular outflow tract obstruction
• Mitral valve replacement in selected cases |
|
Diet and Activity (Hypertrophic Cardiomyopathy)
|
Avoid dehydration
|
|
Complications (Hypertrophic Cardiomyopathy)
|
• Sudden cardiac death
• Atrial fibrillation • Heart failure • Infective endocarditis |
|
Prevention (Hypertrophic Cardiomyopathy)
|
• Genetic counseling
• Endocarditis prophylaxis |
|
Practice Guidelines (Hypertrophic Cardiomyopathy)
|
• The major indication for treatment is the presence of symptoms
• The only therapy to prolong life is an AICD. Patients with several high-risk factors should be considered for this therapy |
|
Prognosis of High-Risk Features (Hypertrophic Cardiomyopathy)
|
• Risk of sudden death is 1 - 4% annually
• Risk predictors: - the younger the disease presents - ventricular arrhythmias or syncope - family history of sudden death - marked left ventricular hypertrophy - hypotension with exercise |
|
Essentials of Diagnosis (Dilated Cardiomyopathy)
|
• Dilation of both ventricles with diffusely reduced contractile functions
• Idiopathic though 25-30% may be genetic |
|
General Consideration (Dilated Cardiomyopathy)
|
• Hallmark: reduced contractile functions & dilations of both ventricles
• Most common type of cardiomyopathy (accounts for 25% of CHF) • Black or Male most likely (much more than white or female) • affects any age range • can also manifest after viral myocarditis |
|
Symptoms and Signs (Dilated Cardiomyopathy)
|
• decreased exercise tolerance
• dyspnea • orthopnea • paroxysmal nocturnal dyspnea • fatigue • palpitations • presyncope or syncope |
|
Physical Exam Findings (Dilated Cardiomyopathy)
|
• tachycardia
• tachypnea • jugular venous distention may be present • pulmonary rales • laterally displaced and diffuse PMI; left and right ventricular lifts Soft S1, paradoxically split S2 with a left bundle branch block • S3 and S4 gallops • hepatomegaly due to elevated venous pressures • ascites, peripheral edema |
|
Differential Diagnosis (Dilated Cardiomyopathy)
|
• Ischemic cardiomyopathy
• valvular heart disease • hypertensive heart disease • alcoholic cardiomyopathy • cardiomyopathy related to thyroid dysfunction • HIV cardiomyopathy |
|
Lab Tests (Dilated Cardiomyopathy)
|
• electrolytes, BUN and creatinine
• CBC • liver function tests: elevations may be due to hepatic congestion • cardiac enzymes: to exclude acute or recent myocardial injury • thyroid function tests: rule out hyperthyroidism • urine pregnancy test: in women of childbearing age • urine toxicology screen |
|
Electrocardiography (Dilated Cardiomyopathy)
|
• PVCs/Ectopy
• nonspecific ST- and T-wave changes • LVH • LBBB • +/- AV blocks |
|
Imaging Studies: X-ray (Dilated Cardiomyopathy)
|
• enlarged cardiac silhouette
• pulmonary vascular congestion • pleural effusions |
|
Imaging Studies: Echocardiography (Dilated Cardiomyopathy)
|
• all four cardiac chambers are typically enlarged, reduced LV fxn
• MR and TR from annular dilation |
|
Diagnostic Procedures (Dilated Cardiomyopathy)
|
• stress test/Nuc: eliminate coronary artery disease as cause
• endomyocardial bx: only if you suspect cardiac amyloidosis in pre-transplant pt |
|
Medications (Dilated Cardiomyopathy)
|
• Treat for CHF
- ACE-1. beta blockers, spironolactone, diuretics, +/- digoxin - low sodium diet and fluid restriction • Treat any A-Fib to prevent RVR (e.g. propranolol) |
|
Therapeutic Procedures (Dilated Cardiomyopathy)
|
• Automatic Internal Cardiac Defibrillator (AICD) in patients with an EF <35%
• Cardiac Resynchronization Therapy (CRT) aka Biventricular Pacing, Bi-V Pacing |
|
Surgery (Dilated Cardiomyopathy)
|
• Cardiac transplantation in atients w/ severe progressive disease despite optimal therapy
• left and right ventricular assist devices (LVAD) may be used as a bridge to cardiac transplantation or as destination therapy in some who are not candidates for heart transplantation |
|
Diet and Activity (Dilated Cardiomyopathy)
|
• low-sodium, fluid-restricted diet
• mild to moderate regular exercise encouraged; cardiac rehabiliation shown to improve patient outcomes |
|
Complications (Dilated Cardiomyopathy)
|
• progressive heart failure
• arrhythmias • sudden death • complications of device implantation: perforation with myocardial rupture and cardiac tamponade, infection and bleeding |
|
Prognosis (Dilated Cardiomyopathy)
|
• depends on severity of of symptoms
- generally, approx 50-80% 5-year survival rate - patients w/ advanced disease less than/equal to 50% 1-year survival rate • Approx 10% patients have spontaneous improvement, normalization of cardiac function |
|
Prevention (Dilated Cardiomyopathy)
|
Avoidance of all cardiotoxic agents and treatment of any underlying condition that has been associated w/ dilated cardiomyopathy
|
|
Practice Guidelines (Dilated Cardiomyopathy)
|
• patients w/ NYHA class III-IV symptoms and intraventricular conduction delay should be considered for CRT (and refer for transplant)
• patients w/ left ventricular EF less than/equal to 35% should be considered for an AICD |
|
Key Features & Essentials of Diagnosis (Restrictive Cardiomyopathy)
|
• symptoms & signs of heart failure w/ mainly right-sided findings
• normal left & right ventricular size and systolic function w/ dilated atria • abnormalities of diastolic ventricular function suggestive of reduced ventricular compliance * Increased ventricular filling pressure (left > right) and reduced cardiac output |
|
General Considerations: Rarity (Restrictive Cardiomyopathy)
|
only 5% of all cases of primary cardiomyopathies
|
|
General Considerations: Causes (Restrictive Cardiomyopathy)
|
• linfiltrative processes (e.g. amyloidosis (MOST COMMON CAUSE!!!), hemochromatosis, sarcoidosis, glycogen storage disease)
• Eosinophilic endomyocarditis • endomyocardial fibrosis (in Africa, called Loffler Syndrome) • Other: metastatic malignancy, carcinoid heart disease, mediastinal radiation |
|
General Considerations: Disease Course (Restrictive Cardiomyopathy)
|
the course varies depending on the pathology
|
|
General Considerations: Pathophysiology (Restrictive Cardiomyopathy)
|
Abnormal myocardial stiffness -> increased diastolic filling pressure -> decreased cardiac output -> heart failure!!
|
|
Symptoms & Signs (Restrictive Cardiomyopathy)
|
• chest pain
• palpitations • one third of patients may present with thromboembolic events • dyspnea and exercise intolerance • fatigue and weakness • increasing abdominal girth (ascites) **THE LAST THREE SYMPTOMS LOOK LIKE HEART DISEASE*** |
|
Physical Exam Findings (Restrictive Cardiomyopathy)
|
• reduced pulse pressure
• tachycardia • JVD • loud S3 • murmurs of mitral and tricuspid • ascites • palpable liver • peripheral edema • decreased breath sounds • pulmonary rales may be heard |
|
Physical Exam Findings: Which three findings look more "congestive" than other cardiomyopathies? (Restrictive Cardiomyopathy)
|
Loud S3, peripheral edema, pulmonary rales may be heard.
|
|
Differential Diagnosis (Restrictive Cardiomyopathy)
|
• Dilated cardiomyopathy w/ restrictive physiology
• hypertrophic cardiomyopathy • constrictive |
|
Lab tests (Restrictive Cardiomyopathy)
|
• rule out eosinophilia
• iron studies to rule out hemochromatosis • serum protein electrophoresis & serum and urine immunofixation to rule in/out amyloid |
|
Electrocardiography (Restrictive Cardiomyopathy)
|
• sinus sythmn, sinus tachycardia or atrial arrhythmias may be present
• varying degrees of atrioventricular block may be present • Low QRS voltage * • Nonspecific ST & T-wave abnormalities * * = bolded in notes, therefore important! |
|
Imaging Studies: Chest X-ray (Restrictive Cardiomyopathy)
|
• dilated atria with normal ventricular size
• signs of CHF |
|
Imaging Studies: ECHO (Restrictive Cardiomyopathy)
|
• restrictive diastolic
• normally contracting right and left ventricles w/ normal or increased (infiltrative diseases) wall thickness w/ normal or reduced ventricular cavity size • markedly dilated atria • maybe some mural thrombi; maybe some valve insufficiency • Doppler evidence of restrictive diastolic filling pattern * * bolded = important!! |
|
Medications (Restrictive Cardiomyopathy)
|
• decrease ventricular preload w/ loop diuretics
• get rid of a-fib or at least maintain rate control of a-fib • anticoagulation for those w/ atrial fibrillation & endocardial fibrosis • treatment of the underlying systemic disease |
|
Therapeutic Procedures (Restrictive Cardiomyopathy)
|
pacing for extreme bradycardia or conduction block
|
|
Surgery (Restrictive Cardiomyopathy)
|
• transplant in severe, refractory heart failure
• surgical resection of endocardial fibrosis in selected cases |
|
Diet & Activity (Restrictive Cardiomyopathy)
|
• two-gram dietary sodium restriction
• activity as tolerated |
|
Complications (Restrictive Cardiomyopathy)
|
• Progressive heart failure *
• atrial and ventricular tachyarrhythmias • heart block • sudden death • thromboembolic events • syncope * = important |
|
Prognosis (Restrictive Cardiomyopathy)
|
• largely depends on underlying pathology
• survival limited for most patients - 70% die within 5 years of sx onset!!! |
|
Practice Guidelines (Restrictive Cardiomyopathy)
|
• Restrictive cardiomyopathy should be considered in patients w/ signs & symptoms of progressive congestive heart failure and preserved ventricular systolic function
• hemodynamic findings - useful to distinguish restriction from constriction include: - right ventricular systolic pressure greater than 50 mm Hg - greater than/equal to 5 mm Hg difference between right and left ventricular end-diastolic pressures - absence of respirophasic variation in left-sided filling pressures - marked atrial dilatation - absence of pericardial thickening and calcification |
|
Key Features & Essentials of Diagnosis (Myocarditis)
|
• Presentation: new onset CHF with preceding viral syndrome (looks like an MI but it isn't!)
• Labs: increases ESR +/- cardiac biomarkers w/ acute myocarditis • ECG: sinus tachycardia, nonspecific ST-T changes*, atrial or ventricular arrhythmias, or conduction abnormalities • Echo: chambe enlargement, globally reduced left ventricular (LV) contractility • Warning: mural thrombi may be present!! * = important!! |
|
General Considerations (Myocarditis)
|
• Inflammatory disease of cardiac muscle
• can be acute, subacute, chronic • most commonly initiated by viral infection* - tho may occur as a result of other infectious organisms, drugs, toxins, collagen vascular diseases, or autoimmune or hypersensitivy reactions • Coxsackie B* = most common virus associated w/ myocarditis (others include adenovirus, echovirus, influenza virus, Hep C, cytomegalovirus, and parvovirus B19 • endomyocardial Bx (not recommended): inflammatory infiltrate w/ adjacent myocyte injury |
|
Symptoms & Signs (Myocarditis)
|
• usually asymptomatic
• preceding viral syndrome • chest pain ** • dyspnea, fatigue, decreased exercise tolerance ** • palpitations, dizziness or syncope ** • cardiogenic shock ** ** = think new onset CHF!!! |
|
Physical Exam Findings (Myocarditis)
|
• fever
• tachycardia • hypotension ** • signs of fluid overload ** • murmurs of mitral or tricuspid regurgitation ** • S3 and occasionally S4 gallops ** • pleural rubs and pericardial friction ** • Circulatory collapse and shock (rare) ** **= think new onset CHF!!! |
|
Differential Diagnosis (Myocarditis)
|
• Acute myocarcial ischemia or infarction due to coronary artery disease
• pneumonia • congestive heart failure due to other causes |
|
Lab Tests (Myocarditis)
|
Increased ESR and increased Troponin T or I and CK-MB seen in some patients
|
|
Electrocardiography (Myocarditis)
|
• nonspecific ST-T wave changes, ectopy
• atrial tachycardia or fibrillation and AV blocks or bundle brance blocks |
|
Imaging Studies (Myocarditis)
|
• Chest x-ray: normal or cardiomegaly, may have pulmonary edema
• Echocardiography: LV enlargement; globally reduced LV contractility, mural thrombi may be present • Gallium-67 imaging: highly sensitive for identifying active inflammation (but rarely ordered!!!!!) |
|
Diagnostic Procedures (Myocarditis)
|
• Cardiac catheterization: only if the presentation really looks like acute myocardial infarction
• Endomyocardial biopsy: considered the gold stadard for establishing the diagnosis; however rarely used due to poor sensitivity |
|
Medications (Myocarditis)
|
• narcotic analgesics for pain relief
• specific antimicrobial treatment if an infections agent is indentified • Treat CHF - ACE-I - beta blockers - Ddigoxin - spironolactone - diuretics (lasix) • Avoid NSAIDS • steroids are NOT helpful except in giant cell myocarditis and autoimmune diseases (e.g. SLE) |
|
Therapeutic Procedures (Myocarditis)
|
• pericatdiocentisis for pericardial effusion and signs of cardiac tamponade
• pacemaker insertion for heart block |
|
Diet and Activity (Myocarditis)
|
• low-sodium diet and fluid restriction in patients with CHF
• restrict activity until ECG returns to normal |
|
Prognosis (Myocarditis)
|
• transplantation: patients have increased risk of recurrent myocarditis and transplant rejection
• Of those who develop CHF: 50% get better; 25% same; 25% worse |
|
Practice Guidelines (Myocarditis)
|
• myocarditis may present subtly and should be considered in patients with chest pain and signs of heart failure
• most patients respond to medical therapy alone • endomyocardial biopsy should be considered in patients with heart failure refractory to medical therapy*, a rapidly deteriorating course* or suspected secondary causes of dilated cardiomyopathy* * = IMPORTANT!! |